Jed A. Latkin
2018
In 2018, Jed A. Latkin earned a total compensation of $639.9K as Chief Executive Officer, Chief Operating Officer and Chief Financial Officer at Navidea Biopharmaceuticals, a 21% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $271,875 |
|---|---|
| Salary | $362,500 |
| Other | $5,500 |
| Total | $639,875 |
Latkin received $362.5K in salary, accounting for 57% of the total pay in 2018.
Latkin also received $271.9K in non-equity incentive plan and $5.5K in other compensation.
Rankings
In 2018, Jed A. Latkin's compensation ranked 11,041st out of 14,244 executives tracked by ExecPay. In other words, Latkin earned more than 22.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,041 out of 14,244 | 23rd |
Division Manufacturing | 4,444 out of 5,758 | 23rd |
Major group Chemicals And Allied Products | 1,683 out of 2,119 | 21st |
Industry group Drugs | 1,427 out of 1,808 | 21st |
Industry In Vitro and In Vivo Diagnostic Substances | 52 out of 72 | 28th |
Source: SEC filing on June 28, 2019.
Latkin's colleagues
We found four more compensation records of executives who worked with Jed A. Latkin at Navidea Biopharmaceuticals in 2018.
News
Navidea Biopharmaceuticals CEO Jed Latkin's 2021 pay rises 10% to $1.3M
October 24, 2022
Navidea Biopharmaceuticals CEO Jed Latkin's 2020 pay jumps 66% to $1.2M
August 2, 2021
Navidea Biopharmaceuticals CEO Jed Latkin's 2019 pay rises 16% to $740K
July 31, 2020
Navidea Biopharmaceuticals CEO Michael Goldberg's 2018 pay jumps 76% to $1.5M
June 28, 2019